A biomarker for both ALS and FTD, 2 neurological disorders that share clinical, genetic, and pathological traits, can help signal disease onset and the progression of degeneration.
When making a diagnosis, rheumatologists must consider the fact that rheumatoid arthritis and some infectious diseases have overlapping musculoskeletal manifestations.
Lavanya Visvabharathy, PhD, Anna Cervantes-Arslanian, MD, and Jonathan Rogers, PhD, provide a closer look into the phenomenon known as “long-haul COVID” and its potential neurologic effects.
Research has revealed that the SARS-CoV-2 viral infection may have neurological manifestations, with critical implications for clinical practice.
